The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Olmesartan Medoxomil Clonmel 40 mg film-coated tablet

Clonmel Healthcare LtdPA0126/273/003

Main Information

Trade NameOlmesartan Medoxomil Clonmel 40 mg film-coated tablet
Active SubstancesOlmesartan medoxomil
Dosage FormFilm-coated tablet
Licence HolderClonmel Healthcare Ltd
Licence NumberPA0126/273/003

Group Information

ATC CodeC09CA Angiotensin II antagonists, plain
C09CA08 olmesartan medoxomil


License statusAuthorised
Licence Issued20/05/2016
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version

Generics Information

Interchangeable List CodeIC0105-004-003
Interchangeable List DocumentPDF of Interchangeable List
« Back